Developing a Novel Imaging Biomarker in the Differential Diagnosis of Parkinson's Disease and Parkinsonism
Status:
Completed
Trial end date:
2018-07-31
Target enrollment:
Participant gender:
Summary
This study will compare the brain uptake of 18F- DTBZ in 20 patients with PD, 20 patients
with MSA, 20 patients with PSP, 20 patients with CBS, and 20 patients with VaP, 20 patients
with ET, and 10 patients with DT.